These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 28958073)

  • 21. Single-centre experience of 85 patients with a continuous-flow left ventricular assist device: clinical practice and outcome after extended support.
    Lok SI; Martina JR; Hesselink T; Rodermans BF; Hulstein N; Winkens B; Klöpping C; Kirkels JH; Doevendans PA; Ramjankhan F; de Weger RA; de Jonge N; Lahpor JR
    Eur J Cardiothorac Surg; 2013 Sep; 44(3):e233-8. PubMed ID: 23868955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HeartMate II Left Ventricular Assist Device Pump Exchange: A Single-Institution Experience.
    Shaikh AF; Joseph SM; Lima B; Hall SA; Malyala R; Rafael AE; Gonzalez-Stawinski GV; Chamogeorgakis T
    Thorac Cardiovasc Surg; 2017 Aug; 65(5):410-414. PubMed ID: 27903010
    [No Abstract]   [Full Text] [Related]  

  • 23. Outcomes of pediatric patients supported by the HeartMate II left ventricular assist device in the United States.
    Cabrera AG; Sundareswaran KS; Samayoa AX; Jeewa A; McKenzie ED; Rossano JW; Farrar DJ; Frazier OH; Morales DL
    J Heart Lung Transplant; 2013 Nov; 32(11):1107-13. PubMed ID: 24002006
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients: Results From the ROADMAP Study.
    Estep JD; Starling RC; Horstmanshof DA; Milano CA; Selzman CH; Shah KB; Loebe M; Moazami N; Long JW; Stehlik J; Kasirajan V; Haas DC; O'Connell JB; Boyle AJ; Farrar DJ; Rogers JG;
    J Am Coll Cardiol; 2015 Oct; 66(16):1747-1761. PubMed ID: 26483097
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adverse events in contemporary continuous-flow left ventricular assist devices: A multi-institutional comparison shows significant differences.
    Stulak JM; Davis ME; Haglund N; Dunlay S; Cowger J; Shah P; Pagani FD; Aaronson KD; Maltais S
    J Thorac Cardiovasc Surg; 2016 Jan; 151(1):177-89. PubMed ID: 26545967
    [TBL] [Abstract][Full Text] [Related]  

  • 26. First experiences with HeartMate 3 follow-up and adverse events.
    Hanke JS; Dogan G; Rojas SV; Zoch A; Feldmann C; Deniz E; Avsar M; Warnecke G; Haverich A; Schmitto JD
    J Thorac Cardiovasc Surg; 2017 Jul; 154(1):173-178. PubMed ID: 28268010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Healthcare Resource Use and Cost Implications in the MOMENTUM 3 Long-Term Outcome Study.
    Mehra MR; Salerno C; Cleveland JC; Pinney S; Yuzefpolskaya M; Milano CA; Itoh A; Goldstein DJ; Uriel N; Gulati S; Pagani FD; John R; Adamson R; Bogaev R; Thohan V; Chuang J; Sood P; Goates S; Silvestry SC
    Circulation; 2018 Oct; 138(18):1923-1934. PubMed ID: 29807933
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Five-Year Outcomes in Patients With Fully Magnetically Levitated vs Axial-Flow Left Ventricular Assist Devices in the MOMENTUM 3 Randomized Trial.
    Mehra MR; Goldstein DJ; Cleveland JC; Cowger JA; Hall S; Salerno CT; Naka Y; Horstmanshof D; Chuang J; Wang A; Uriel N
    JAMA; 2022 Sep; 328(12):1233-1242. PubMed ID: 36074476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term heart transplant outcomes after lowering fixed pulmonary hypertension using left ventricular assist devices.
    Moayedifar R; Zuckermann A; Aliabadi-Zuckermann A; Riebandt J; Angleitner P; Dimitrov K; Schloeglhofer T; Rajek A; Laufer G; Zimpfer D
    Eur J Cardiothorac Surg; 2018 Dec; 54(6):1116-1121. PubMed ID: 29905775
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Short-term single-centre experience with the HeartMate 3 left ventricular assist device for advanced heart failure.
    Nowacka A; Hullin R; Tozzi P; Barras N; Regamey J; Yerly P; Rosner L; Marcucci C; Rusca M; Liaudet L; Kirsch M
    Eur J Cardiothorac Surg; 2020 Sep; 58(3):511-518. PubMed ID: 32236472
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stroke and Intracranial Hemorrhage in HeartMate II and HeartWare Left Ventricular Assist Devices: A Systematic Review.
    Cho SM; Moazami N; Frontera JA
    Neurocrit Care; 2017 Aug; 27(1):17-25. PubMed ID: 28324260
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcomes after implantation of 139 full-support continuous-flow left ventricular assist devices as a bridge to transplantation.
    Sabashnikov A; Mohite PN; Weymann A; Patil NP; Hedger M; Sáez DG; Zych B; Wahlers T; Wippermann J; De Robertis F; Bahrami T; Amrani M; Simon AR; Popov AF
    Eur J Cardiothorac Surg; 2014 Nov; 46(5):e59-66. PubMed ID: 25180072
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Midterm outcome of implantable left ventricular assist devices as a bridge to transplantation: Single-center experience in Japan.
    Kimura M; Kinoshita O; Nawata K; Nishimura T; Hatano M; Imamura T; Endo M; Kagami Y; Kubo H; Kashiwa K; Kinugawa K; Kyo S; Komuro I; Ono M
    J Cardiol; 2015 May; 65(5):383-9. PubMed ID: 25034705
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcomes and hospital admissions during long-term support with a HeartMate II.
    Rossing K; Jung MH; Sander K; Olsen PS; Hansen PB; Boesgaard S; Gustafsson F
    Scand Cardiovasc J; 2015; 49(6):367-75. PubMed ID: 26400060
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Temporal Differences in Outcomes During Long-Term Mechanical Circulatory Support.
    Maltais S; Anwer LA; Haglund NA; Cowger J; Shah P; Aaronson KD; Pagani FD; Dunlay SM; Singh R; Salerno CT; Stulak JM
    J Card Fail; 2017 Dec; 23(12):852-858. PubMed ID: 28757150
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical Outcomes of Patients Treated With Pulmonary Vasodilators Early and in High Dose After Left Ventricular Assist Device Implantation.
    Critoph C; Green G; Hayes H; Baumwol J; Lam K; Larbalestier R; Chih S
    Artif Organs; 2016 Jan; 40(1):106-14. PubMed ID: 25994765
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Three-year follow-up after less-invasive left ventricular assist device exchange to HeartMate 3™.
    Hanke JS; Mariani S; Merzah AS; Bounader K; Li T; Haverich A; Schmitto JD; Dogan G
    J Cardiovasc Surg (Torino); 2021 Dec; 62(6):646-651. PubMed ID: 34057162
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term follow-up of patients supported with the HeartWare left ventricular assist system.
    Al Masri E; Al Shakaki M; Welp H; Scherer M; Dell'Aquila AM
    Artif Organs; 2020 Oct; 44(10):1061-1066. PubMed ID: 32216106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patient survival and therapeutic outcome in the UK bridge to transplant left ventricular assist device population.
    Parameshwar J; Hogg R; Rushton S; Taylor R; Shaw S; Mehew J; Simon A; MacGowan GA; Dalzell JR; Al Attar N; Venkateswaran R; Lim HS; Schueler S; Tsui S; Banner NR
    Heart; 2019 Feb; 105(4):291-296. PubMed ID: 30121631
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HeartMate left ventricular assist device as bridge to heart transplantation.
    Koul B; Solem JO; Steen S; Casimir-Ahn H; Granfeldt H; Lönn UJ
    Ann Thorac Surg; 1998 Jun; 65(6):1625-30. PubMed ID: 9647070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.